Natixis Investment Managers International’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-167,670
Closed -$251K 226
2022
Q3
$251K Buy
167,670
+9,600
+6% +$19.7K 0.02% 127
2022
Q2
$357K Buy
+158,070
New +$458K 0.01% 342
2022
Q1
Sell
-158,070
Closed -$1.17M 463
2021
Q4
$1.17M Buy
158,070
+31,460
+25% +$229K 0.06% 71
2021
Q3
$1.01M Buy
126,610
+49,395
+64% +$479K 0.06% 75
2021
Q2
$955K Buy
+77,215
New +$916K 0.06% 86

Other funds holding AVAH

Natixis Investment Managers International's AVAH Position: Q4 2022 in Review

Natixis Investment Managers International sold out of Aveanna Healthcare (AVAH) in Q4 2022, closing a stake of 167,670 shares — an estimated $251K sold.

Natixis Investment Managers International first reported a position in AVAH in Q2 2021 and held it in 5 quarters. The position peaked at $1.17M in Q4 2021. 81 funds tracked by Wall St. Rank hold AVAH as of Q4 2022.

  • Natixis Investment Managers International reported no remaining Aveanna Healthcare position as of Q4 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 167,670 Aveanna Healthcare shares in Q4 2022, an estimated $251K.
  • Natixis Investment Managers International first reported a position in Aveanna Healthcare in Q2 2021 and held it in 5 quarters.
  • Natixis Investment Managers International's Aveanna Healthcare position peaked at $1.17M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q4 2022.

Based on Natixis Investment Managers International's 13F filing for Q4 2022, filed 13 Feb 2023.